Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
24. November 2025

Powerful Medical Wins MedTech Innovator 2025

Powerful Medical team receiving the MedTech Innovator 2025 Mid-Stage Grand Prize award on stage, holding a large winner’s check.

New York, Nov 24, 2025 – Powerful Medical today announced that it has won MedTech Innovator’s (MTI) 2025 Mid-Stage Grand Finals, earning the prestigious title of “MedTech Innovator 2025.” This award is the top honor from the world’s largest life-science accelerator.

As a finalist, Powerful Medical competed at the MedTech Strategist Innovation Summit, November 19-21, 2025, in San Diego, California. Powerful Medical presented PMcardio with its FDA Breakthrough-designated Queen of Hearts™ AI ECG technology that enables early and accurate detection of severe heart attacks — particularly STEMI and STEMI equivalents — across pre-hospital, point-of-care, and emergency care environments.

“Winning MedTech Innovator’s 2025 Mid-Stage Grand Finals competition is an extraordinary achievement,” said Martin Herman, Co-Founder & CEO of Powerful Medical. “This recognition validates our mission to transform acute cardiac care. With PMcardio and the Queen of Hearts AI, clinicians can diagnose life-threatening heart attacks with twice the sensitivity of the current standard of care — and do so at first medical contact, when every minute determines how much of the heart can still be saved.”

Powerful Medical just recently made headlines with its late-breaking clinical science data presented at TCT 2025, demonstrating that using the Queen of Hearts STEMI AI ECG model to analyze electrocardiograms (ECGs) significantly improves detection of severe heart attacks while reducing false-positive cath lab activations five fold.

Further strengthening these findings, the largest RCT of AI in cardiology—the multicenter DIFOCCULT-3 randomized controlled trial with 6,000 ACS patients—demonstrated that integrating Queen of Hearts AI into clinical workflows resulted in nearly a 5-hour decrease in ECG-to-balloon time. This marks a significant improvement in the timeliness of definitive treatment.

Together, these landmark results position Powerful Medical to reshape first-medical-contact diagnosis and the global standard of care for severe heart attacks.

In the 2025 MTI cohort, selected from nearly 1,500 global applicants, Powerful Medical took home the title of MedTech Innovator 2025 and won the Mid-Stage Grand Finals.


About PMcardio and Powerful Medical

PMcardio is a diagnostic and care coordination platform developed by Powerful Medical, a medical device manufacturer specializing in AI-driven cardiovascular diagnostics. Clinically validated to detect 49 cardiac conditions from an ECG, it identifies acute heart attacks up to three hours earlier and with twice the sensitivity of the current standard of care. This enables timely and accurate triage in emergency settings. By reducing treatment delays and door-to-balloon times, PMcardio facilitates optimized care for chest pain patients. Already class IIb CE-marked under EU MDR in Europe, and pending FDA approval, it enhances acute cardiac care by supporting faster, more confident clinical decisions.

About MedTech Innovator

MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing nearly 14,000 applicants and fostering the growth of over 800 graduates. Alumni have collectively raised $10+ billion in follow-on funding and introduced 500+ products to the market, improving the health of millions worldwide. In 2025, MTI selected 64 companies from nearly 1,500 global applicants for its highly competitive accelerator cohort, representing the top 4% of innovations worldwide. Companies benefit from MTI’s comprehensive program of mentorship, strategic guidance, and access to an unparalleled network of medtech strategics, investors, providers, and payers. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow them on LinkedIn, and subscribe to its monthly newsletter.

Powerful Medical Wins MedTech Innovator 2025
Powerful Medical Wins MedTech Innovator 2025

Stay on the pulse with our newsletter

Your submission was successful

Media Kit and Press Resources

For journalists, partners, and conference organizers — access official press materials, study visuals, company background, and leadership bios in the Powerful Medical Media Kit.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

Share this article

Don't miss these

PMcardio Reports Positive RCT Results and Late-Breaking Clinical Science for STEMI Detection

PMcardio’s AI-powered ECG technology delivers breakthrough results at TCT 2025—improving heart attack detection, reducing false activations, and enabling faster treatment across major clinical trials, including the landmark DIFOCCULT-3 RCT.

Independent RCT and Late-Breaking Science: PMcardio to Take Center Stage at TCT 2025

We’re proud to share that PMcardio and the Queen of Hearts™ (STEMI AI ECG model) will be prominently featured at Transcatheter Cardiovascular Therapeutics (TCT) 2025, the largest interventional cardiology conference in the U.S., taking place October 25–27, 2025 in San Francisco, California.

Join over 100,000 healthcare professionals who are already taking advantage of AI